Generic Competition May Have Taken A Bite Out Of Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The statin’s sales got off to a sluggish start in the first quarter but Pfizer maintains the drug will reach its $13 bil. revenue target for the year.